BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15194790)

  • 41. The hematopoietic cell-specific Rho GTPase inhibitor ARHGDIB/D4GDI limits HIV type 1 replication.
    Watanabe T; Urano E; Miyauchi K; Ichikawa R; Hamatake M; Misawa N; Sato K; Ebina H; Koyanagi Y; Komano J
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):913-22. PubMed ID: 21936715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV entry and tropism: the chemokine receptor connection.
    Berger EA
    AIDS; 1997; 11 Suppl A():S3-16. PubMed ID: 9451961
    [No Abstract]   [Full Text] [Related]  

  • 43. An anti-HIV peptide construct derived from the cleavage region of the Env precursor acts on Env fusogenicity through the presence of a functional cleavage sequence.
    Barbouche R; Sabatier JM; Fenouillet E
    Virology; 1998 Aug; 247(2):137-43. PubMed ID: 9705906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of chemokine receptor conformational heterogeneity on HIV infection.
    Baribaud F; Doms RW
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):653-60. PubMed ID: 11502072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse.
    Jolly C; Kashefi K; Hollinshead M; Sattentau QJ
    J Exp Med; 2004 Jan; 199(2):283-93. PubMed ID: 14734528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell-dependent mechanisms restrict the HIV type 1 coreceptor activity of US28, a chemokine receptor homolog encoded by human cytomegalovirus.
    Ohagen A; Li L; Rosenzweig A; Gabuzda D
    AIDS Res Hum Retroviruses; 2000 Jan; 16(1):27-35. PubMed ID: 10628814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Varying effects of temperature, Ca(2+) and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins.
    Jernigan KM; Blumenthal R; Puri A
    FEBS Lett; 2000 Jun; 474(2-3):246-51. PubMed ID: 10838094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Battling AIDS.
    Nat Struct Biol; 1999 Oct; 6(10):895-6. PubMed ID: 10504715
    [No Abstract]   [Full Text] [Related]  

  • 49. The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.
    Brighty DW; Jassal SR
    J Virol; 2001 Nov; 75(21):10472-8. PubMed ID: 11581416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling.
    Raviv Y; Viard M; Bess J; Blumenthal R
    Virology; 2002 Feb; 293(2):243-51. PubMed ID: 11886244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opposite effects of two different strains of equine herpesvirus 1 infection on cytoskeleton composition in equine dermal ED and African green monkey kidney Vero cell lines: application of scanning cytometry and confocal-microscopy-based image analysis in a quantitative study.
    Turowska A; Pajak B; Godlewski MM; Dzieciatkowski T; Chmielewska A; Tucholska A; Banbura M
    Arch Virol; 2010 May; 155(5):733-43. PubMed ID: 20349252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of human immunodeficiency virus envelope glycoprotein- mediated single cell lysis by low-molecular-weight antagonists of viral entry.
    Madani N; Hubicki AM; Perdigoto AL; Springer M; Sodroski J
    J Virol; 2007 Jan; 81(2):532-8. PubMed ID: 16943294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fusion of human immunodeficiency virus-infected cells with uninfected cells.
    Lifson JD
    Methods Enzymol; 1993; 221():3-12. PubMed ID: 8361381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2.
    Dragic T; Alizon M
    J Virol; 1993 Apr; 67(4):2355-9. PubMed ID: 8095307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry.
    Rucker J; Doranz BJ; Edinger AL; Long D; Berson JF; Doms RW
    Methods Enzymol; 1997; 288():118-33. PubMed ID: 9356991
    [No Abstract]   [Full Text] [Related]  

  • 56. A new SIV co-receptor, STRL33.
    Alkhatib G; Liao F; Berger EA; Farber JM; Peden KW
    Nature; 1997 Jul; 388(6639):238. PubMed ID: 9230431
    [No Abstract]   [Full Text] [Related]  

  • 57. High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells.
    Blanco J; Bosch B; Fernández-Figueras MT; Barretina J; Clotet B; Esté JA
    J Biol Chem; 2004 Dec; 279(49):51305-14. PubMed ID: 15371410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A model of localised Rac1 activation in endothelial cells due to fluid flow.
    Allen RJ; Bogle ID; Ridley AJ
    J Theor Biol; 2011 Jul; 280(1):34-42. PubMed ID: 21439300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gelsolin activity controls efficient early HIV-1 infection.
    García-Expósito L; Ziglio S; Barroso-González J; de Armas-Rillo L; Valera MS; Zipeto D; Machado JD; Valenzuela-Fernández A
    Retrovirology; 2013 Apr; 10():39. PubMed ID: 23575248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apoptosis and karyogamy in syncytia induced by the HIV-1-envelope glycoprotein complex.
    Ferri KF; Jacotot E; Geuskens M; Kroemer G
    Cell Death Differ; 2000 Nov; 7(11):1137-9. PubMed ID: 11288697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.